Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluating the Effectiveness of Anti- Ulcerants (Dexlansoprazole, Lansoprazole, and Vonoprazan) With Levofloxacin-based Triple Therapy for Helicobacter Pylori Eradication - A Three-arm Randomized Controlled Trial

NCT07344506 is registered in ClinicalTrials.gov with Dow University of Health Sciences as lead sponsor.

NCT NCT07344506
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07344506 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluating the Effectiveness of Anti- Ulcerants (Dexlansoprazole, Lansoprazole, and Vonoprazan) With Levofloxacin-based Triple Therapy for Helicobacter Pylori Eradication - A Three-arm Randomized Controlled Trial
Lead sponsor
Dow University of Health Sciences
Phase
Phase 4
Overall status
Recruiting
Start date
May 1, 2025
Completion date
August 1, 2026
Enrollment
942 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

h. pylori gastrointestinal disease, h.pylori eradication rate, h.pylori infection